Special Issue “Cutaneous Lymphomas”
Author Contributions
Conflicts of Interest
References
- Willemze, R.; Cerroni, L.; Kempf, W.; Berti, E.; Facchetti, F.; Swerdlow, S.H.; Jaffe, E.S. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019, 133, 1703–1714. [Google Scholar] [CrossRef] [PubMed]
- Dummer, R.; Vermeer, M.H.; Scarisbrick, J.J.; Kim, Y.H.; Stonesifer, C.; Tensen, C.P.; Geskin, L.J.; Quaglino, P.; Ramelyte, E. Cutaneous T cell lymphoma. Nat. Rev. Dis. Prim. 2021, 7, 61. [Google Scholar] [CrossRef] [PubMed]
- Campbell, J.J.; Clark, R.A.; Watanabe, R.; Kupper, T.S. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: A biologic rationale for their distinct clinical behaviors. Blood 2010, 116, 767–771. [Google Scholar] [CrossRef] [PubMed]
- Tensen, C.P.; Quint, K.D.; Vermeer, M.H. Genetic and epigenetic insights into cutaneous T-cell lymphoma. Blood 2022, 139, 15–33. [Google Scholar] [CrossRef]
- Lindahl, L.M.; Willerslev-Olsen, A.; Gjerdrum, L.M.R.; Nielsen, P.R.; Blümel, E.; Rittig, A.H.; Celis, P.; Herpers, B.; Becker, J.C.; Stausbøl-Grøn, B.; et al. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma. Blood 2019, 134, 1072–1083. [Google Scholar] [CrossRef] [PubMed]
- Khodadoust, M.S.; Mou, E.; Kim, Y.H. Integrating Novel Agents into the Treatment of Advanced Mycosis Fungoides and Sézary Syndrome. Blood 2022, 141, 695–703. [Google Scholar] [CrossRef] [PubMed]
- Scarisbrick, J.J.; Prince, H.M.; Vermeer, M.H.; Quaglino, P.; Horwitz, S.; Porcu, P.; Stadler, R.; Wood, G.S.; Beylot-Barry, M.; Pham-Ledard, A.; et al. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2015, 33, 3766–3773. [Google Scholar] [CrossRef]
- Dobos, G.; Pohrt, A.; Ram-Wolff, C.; Lebbé, C.; Bouaziz, J.D.; Battistella, M.; Bagot, M.; de Masson, A. Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients. Cancers 2020, 12, 2921. [Google Scholar] [CrossRef]
- Wojewoda, K.; Gillstedt, M.; Englund, H.; Ali, S.; Lewerin, C.; Osmancevic, A. Diagnostic Outcomes and Treatment Modalities in Patients with Mycosis Fungoides in West Sweden-A Retrospective Register-Based Study. Cancers 2022, 14, 4661. [Google Scholar] [CrossRef]
- Trautinger, F.; Eder, J.; Assaf, C.; Bagot, M.; Cozzio, A.; Dummer, R.; Gniadecki, R.; Klemke, C.D.; Ortiz-Romero, P.L.; Papadavid, E.; et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome—Update 2017. Eur. J. Cancer 2017, 77, 57–74. [Google Scholar] [CrossRef] [Green Version]
- Assaf, C.; Waser, N.; Bagot, M.; He, M.; Li, T.; Dalal, M.; Gavini, F.; Trinchese, F.; Zomas, A.; Little, M.; et al. Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries. Cancers 2021, 14, 145. [Google Scholar] [CrossRef] [PubMed]
- Quaglino, P.; Maule, M.; Prince, H.M.; Porcu, P.; Horwitz, S.; Duvic, M.; Talpur, R.; Vermeer, M.; Bagot, M.; Guitart, J.; et al. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann. Oncol. 2019, 30, 494. [Google Scholar] [CrossRef] [PubMed]
- Maurus, K.; Appenzeller, S.; Roth, S.; Kuper, J.; Rost, S.; Meierjohann, S.; Arampatzi, P.; Goebeler, M.; Rosenwald, A.; Geissinger, E.; et al. Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma. J. Investig. Dermatol. 2018, 138, 1573–1581. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carlsen, E.D.; Swerdlow, S.H.; Cook, J.R.; Gibson, S.E. Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases. Am. J. Surg. Pathol. 2019, 43, 1403–1412. [Google Scholar] [CrossRef] [PubMed]
- Mareschal, S.; Pham-Ledard, A.; Viailly, P.J.; Dubois, S.; Bertrand, P.; Maingonnat, C.; Fontanilles, M.; Bohers, E.; Ruminy, P.; Tournier, I.; et al. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. J. Investig. Dermatol. 2017, 137, 1984–1994. [Google Scholar] [CrossRef] [Green Version]
- Barasch, N.J.K.; Liu, Y.C.; Ho, J.; Bailey, N.; Aggarwal, N.; Cook, J.R.; Swerdlow, S.H. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. Hum. Pathol. 2020, 106, 93–105. [Google Scholar] [CrossRef]
- Wobser, M.; Schummer, P.; Appenzeller, S.; Kneitz, H.; Roth, S.; Goebeler, M.; Geissinger, E.; Rosenwald, A.; Maurus, K. Panel Sequencing of Primary Cutaneous B-Cell Lymphoma. Cancers 2022, 14, 5274. [Google Scholar] [CrossRef]
- Menzer, C.; Rendon, A.; Hassel, J.C. Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab. Cancers 2022, 14, 4787. [Google Scholar] [CrossRef]
- Benner, M.F.; Jansen, P.M.; Vermeer, M.H.; Willemze, R. Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases. Blood 2012, 119, 1643–1649. [Google Scholar] [CrossRef] [Green Version]
- Wobser, M.; Roth, S.; Appenzeller, S.; Houben, R.; Schrama, D.; Goebeler, M.; Geissinger, E.; Rosenwald, A.; Maurus, K. Targeted Deep Sequencing of Mycosis Fungoides Reveals Intracellular Signaling Pathways Associated with Aggressiveness and Large Cell Transformation. Cancers 2021, 13, 5512. [Google Scholar] [CrossRef]
- Karagianni, F.; Piperi, C.; Casar, B.; de la Fuente-Vivas, D.; García-Gómez, R.; Lampadaki, K.; Pappa, V.; Papadavid, E. Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma. Cancers 2022, 14, 1070. [Google Scholar] [CrossRef] [PubMed]
- Jost, M.; Wehkamp, U. The Skin Microbiome and Influencing Elements in Cutaneous T-Cell Lymphomas. Cancers 2022, 14, 1324. [Google Scholar] [CrossRef] [PubMed]
- Lindahl, L.M.; Iversen, L.; Ødum, N.; Kilian, M. Staphylococcus aureus and Antibiotics in Cutaneous T-Cell Lymphoma. Dermatology 2022, 238, 551–553. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wobser, M.; Goebeler, M. Special Issue “Cutaneous Lymphomas”. Cancers 2023, 15, 1481. https://doi.org/10.3390/cancers15051481
Wobser M, Goebeler M. Special Issue “Cutaneous Lymphomas”. Cancers. 2023; 15(5):1481. https://doi.org/10.3390/cancers15051481
Chicago/Turabian StyleWobser, Marion, and Matthias Goebeler. 2023. "Special Issue “Cutaneous Lymphomas”" Cancers 15, no. 5: 1481. https://doi.org/10.3390/cancers15051481
APA StyleWobser, M., & Goebeler, M. (2023). Special Issue “Cutaneous Lymphomas”. Cancers, 15(5), 1481. https://doi.org/10.3390/cancers15051481